Printer Friendly

GLAXO INC. RECEIVES ONE OF NORTH CAROLINA'S TOP ENVIRONMENTAL AWARDS FOR ACHIEVEMENT IN WASTE MANAGEMENT

 RESEARCH TRIANGLE PARK, N.C., April 22 /PRNewswire/ -- A new tablet- coating process that eliminates nearly 480 tons of hazardous waste and 7.5 tons of air emissions a year has earned Glaxo Inc. one of North Carolina's top environmental awards.
 In a ceremony Thursday, Gov. James B. Hunt Jr. presented the North Carolina Governor's Award for Excellence for Outstanding Achievement in Waste Management to Glaxo Inc., one of the nation's leading pharmaceutical companies.
 "It's gratifying to receive this recognition," said Cliff Disbrow, Glaxo senior vice president of Technical Operations, who accepted the award for the company. "It's even more gratifying to see technology improve in ways that prevent so much waste. It's good both economically and environmentally."
 Glaxo earned the award for instituting the new process at its Zebulon, N.C., plant. Changing the process to a water-based coating instead of a solution of methylene chloride and isopropyl alcohol required approval by the Food and Drug Administration. The new process has proved successful and being adopted by other Glaxo manufacturing facilities around the world.
 Glaxo's mission is to improve the quality of life. That's natural for a company dedicated to researching, manufacturing and marketing innovative new medicines. But Glaxo also includes improving the quality of the environment in that mission, which makes the challenge more difficult.
 The Glaxo Group of companies, as a matter of policy, is committed to implementing programs to protect the environment. Glaxo was recognized for its policy at the 1992 "Earth Summit" in Rio de Janeiro, Brazil, by the United Nations Center on Transnational Corporations. Glaxo requires each company within the group to develop its own environmental policy, using governmental regulations as minimum standards.
 Glaxo Inc., the U.S. subsidiary of Glaxo Holdings p.l.c. (NYSE: GLX), has taken several steps, such as the switch to aqueous coating, to fulfill that commitment.
 "It is essential that we act responsibly in our world today, especially in a business like ours," said Charles A. Sanders, M.D., Glaxo Inc. chairman and CEO. "You cannot ignore the health of the environment when your goal is to improve the health of the person. The two are intertwined."
 An example of this commitment is a new program, introduced with the launch of Glaxo's newest product, Imitrex(TM) (sumatriptan succinate). The medicine, a treatment for migraine, is administered through subcutaneous injection, which means there's a syringe to be disposed after each injection. Glaxo has developed the GREEN program -- Glaxo Retrieval Effort for Expended Needles -- to facilitate disposal of the syringes.
 Migraine patients with a prescription for Imitrex who enroll in the program can bring used syringes back to a participating pharmacy in the hard plastic case that comes with each prescription. They will get credit for each returned syringe, and when they have brought back 14, they will receive a certificate redeemable for two prefilled Imitrex syringes with a prescription.
 Patients place the encased used syringes in a "used medical sharps" disposal container. When the container is filled (with about 80 syringes), the pharmacy ships it back to Glaxo in a preaddressed, postpaid carton for disposal.
 Glaxo also is conscientious about disposing of waste generated in its own facilities. The company has a permit for an on-site incinerator at Research Triangle Park. The incinerator will burn biomedical and hazardous chemical waste that is produced by Glaxo's research and development efforts.
 "You can't avoid controversy when you consider constructing an incinerator," said Thomas Cecich, vice president of Environmental and Safety Affairs. But we believe we have a responsibility to properly dispose of the waste we create, especially in our research. It's appropriate that we take as many of the disposal steps as possible right here on site. When such a facility is properly managed and operated, it becomes a safe and effective waste management method."
 Those steps also include recycling of paper, aluminum cans, glass bottles and cardboard. Every employee has a special "recycling" container at his or her desk that is divided into three sections, one for glass and aluminum, one for paper and one for trash. The company also collects outdated telephone books, newspapers and cardboard boxes in all its building to be recycled. Laboratory glass also is recycled separately. Glaxo even recycles laser printer toner cartridges, sending empty toner cartridges to a recycling/remanufacturing vendor.
 The recycling effort is carried out on the other end, too. Glaxo uses recycled paper products -- from notebooks to toilet tissue -- whenever possible.
 Glaxo's eight-member Environmental Council meets monthly to discuss new and better ways to protect the environment. And the company gives donations to several environmental efforts, including "Big Sweep," a statewide waterways cleanup, and the Triangle Tree Program, which provides seedlings and planting information to school children in the area.
 "The pharmaceutical industry in the U.S. leads the world in discovering new ways to treat diseases that affect people," said Dr. Sanders. "We hope we also can lead the world in preserving and protecting our environment."
 -0- 4/22/93
 /CONTACT: Ramona Jones, Corporate Communications, Glaxo Inc., 919-248-2839/
 (GLX)


CO: Glaxo Inc. ST: North Carolina IN: MTC ENV SU:

MM-CM -- CH009 -- 9575 04/22/93 14:39 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 22, 1993
Words:858
Previous Article:WARREN PETROLEUM COMPANY BEGINS FINAL PHASE OF MT. BELVIEU CAPITAL INVESTMENT PROGRAM
Next Article:PUBLIC SERVICE COMPANY BOARD OF DIRECTORS INCREASES QUARTERLY CASH DIVIDEND
Topics:


Related Articles
GLAXO BEGINS SHIPPING MATERNAL AND INFANT HEALTH UNITS TO NORTH CAROLINA COUNTIES
THE GLAXO FOUNDATION GIVES $25,000 TO RECORDING FOR THE BLIND
THE GLAXO FOUNDATION LAUNCHES WOMEN IN SCIENCE SCHOLARS PROGRAM More than $250,000 in Endowed Scholarships Established at 11 NC Schools
INGRAM NAMED GLAXO INC. CEO; SANDERS TO ASSUME POLICY ROLE
GLAXO FOUNDATION EDUCATIONAL AND CULTURAL OUTREACH ENDOWMENT FUND ESTABLISHED AT NATIONAL HUMANITIES CENTER
ARTHUR M. PAPPAS DEPARTS GLAXO FOR NEW VENTURES
WITH A BOOST FROM GLAXO WELLCOME INC. NON-PROFIT KEEPS N.C. TEACHERS CURRENT IN SCIENCE
Robert A. Ingram Named Chief Executive Of Glaxo Wellcome plc
Glaxo Wellcome Seeks 'Public Health Heroes' Involved in N.C. Children's Health.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters